GLP-1 receptor agonists show anti-cancer benefits beyond weight loss, reports research Dr. Kamal Kant Kohli17 May 2025 9:15 AM ISTNew research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal...
Weight-loss drug use risen sharply among children and adults with type 1 diabetes: Study Dr. Kamal Kant Kohli18 April 2025 12:00 PM ISTPopular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the...
GLP-1 diabetes drugs not linked to heightened suicidality risk: Study Dr. Kamal Kant Kohli27 Feb 2025 9:00 AM ISTUse of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with two other groups of...
SGLT2 Inhibitors and GLP-1 Receptor Agonists Linked to Fewer COPD Exacerbations in diabetes patients with COPD: JAMA Dr Riya Dave17 Feb 2025 8:45 AM ISTResearchers had found in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists...
New Dietary Recommendation for Managing Gastrointestinal Issues Treated with GLP-1 Receptor Agonists Dr Jeegar Dattani1 Feb 2025 4:51 PM ISTA recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for individuals using GLP-1...
GLP-1 drugs may reduce surgery complications in patients with diabetes, suggests study Dr. Kamal Kant Kohli15 Jan 2025 8:45 AM ISTPeople with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital...
Diabetes Drugs SGLT2i and GLP-1 RAs may Reduce Risk of Pneumonia and Sepsis, finds research Dr Riya Dave19 Dec 2024 8:15 AM ISTResearchers have discovered that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), often...
GLP-1 receptor agonists also protect kidneys among patients with diabetes and obesity: Lancet Dr. Kamal Kant Kohli2 Dec 2024 8:15 AM ISTThe biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have...
Study Identifies Key Factors Predicting Liver Fibrosis Progression in Type 2 Diabetes with MASLD Medha Baranwal26 Nov 2024 8:45 AM ISTSaudi Arabia: A recent study, published in the Journal of Diabetes and its Complications has identified key predictors of liver fibrosis progression...
GLP-1 receptor agonists may be effective in helping people drink less alcohol, finds study Dr. Kamal Kant Kohli16 Nov 2024 8:45 AM ISTNew research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in...
GLP-1 receptor agonists linked to substantial muscle loss as part of weight loss process: Lancet Dr. Kamal Kant Kohli30 Oct 2024 9:15 AM ISTA recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context of medically induced...
Review Explores Impact of GLP-1 Agonists on Type 2 Diabetes and Weight Management Medha Baranwal16 Oct 2024 8:45 AM ISTUSA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes and obesity. These...
